Clinical positioning and efficacy evaluation of norvancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections
Letters in Drug Design & Discovery · 2026-11 · 100671
DOI: 10.1016/j.lddd.2026.100671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-11. Verfasst von Jing Wang und 6 weiteren Autor:innen. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wang, J., Li, Y., Zhang, Y., Wang, D., Liu, Y., Song, Y., & Li, Y. (2026). Clinical positioning and efficacy evaluation of norvancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections. Letters in Drug Design & Discovery, 100671. https://doi.org/10.1016/j.lddd.2026.100671
Vancouver
Wang J, Li Y, Zhang Y, Wang D, Liu Y, Song Y, et al. Clinical positioning and efficacy evaluation of norvancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections. Letters in Drug Design & Discovery. 2026:100671. doi:10.1016/j.lddd.2026.100671
BibTeX
@article{Wang2026,
author = {Wang, Jing and Li, Yanming and Zhang, Yanjing and Wang, Donghan and Liu, Yan and Song, Yongzhao and Li, Yaqing},
title = {Clinical positioning and efficacy evaluation of norvancomycin in the treatment of methicillin-resistant Staphylococcus aureus infections},
journal = {Letters in Drug Design & Discovery},
year = {2026},
pages = {100671},
doi = {10.1016/j.lddd.2026.100671}
}
EUVIMED